Short answer · Medically reviewed summary · Last updated: 2026-04-06
Achondroplasia is a genetic condition that is inherited in an autosomal dominant pattern, though the vast majority of cases arise from a spontaneous, de novo mutation rather than being passed down from a parent. To clarify the distinction, while Achondroplasia is strictly a genetic condition caused by a mutation in the FGFR3 gene, it is not always "hereditary" in the sense of being inherited from a parent. In approximately 80% of individuals diagnosed with Achondroplasia, the mutation occurs spontaneously for the first time in the affected person, meaning both parents typically have average stature. Inheritance and Risk When Achondroplasia is inherited, it follows an autosomal dominant pattern, meaning only one copy of the mutated gene is required to express the condition.
Achondroplasia is a genetic condition that is inherited in an autosomal dominant pattern, though the vast majority of cases arise from a spontaneous, de novo mutation rather than being passed down from a parent.
To clarify the distinction, while Achondroplasia is strictly a genetic condition caused by a mutation in the FGFR3 gene, it is not always "hereditary" in the sense of being inherited from a parent. In approximately 80% of individuals diagnosed with Achondroplasia, the mutation occurs spontaneously for the first time in the affected person, meaning both parents typically have average stature.
When Achondroplasia is inherited, it follows an autosomal dominant pattern, meaning only one copy of the mutated gene is required to express the condition. If one parent has Achondroplasia, there is a 50% chance for each pregnancy to result in a child with the condition. If both parents have Achondroplasia, there is a 50% chance of the child having the condition, a 25% chance of the child having average stature, and a 25% chance of the child inheriting two copies of the mutation (homozygous Achondroplasia), which is typically lethal in the neonatal period.
Genetic testing for Achondroplasia is highly accurate and involves molecular analysis of the FGFR3 gene. Testing is recommended to confirm a clinical diagnosis or for prenatal evaluation. We strongly encourage families to engage with a genetic counselor, especially when planning a pregnancy. A counselor can provide personalized risk assessments, explain the implications of prenatal diagnosis, and discuss options such as Preimplantation Genetic Testing (PGT) for those undergoing in vitro fertilization.
Because the condition is usually de novo, carrier testing is not applicable in the traditional sense; rather, testing focuses on identifying the specific FGFR3 variant. Understanding your family’s unique genetic context is an empowering step toward proactive health management.
Medical Disclaimer: This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.